E-LIB Suche - Ergebnisse für: Burgstaller, Sonja

1

A multicenter retrospective evaluation of Chronic Myeloid L..:

Petzer, Andreas L. ; Sperr, Wolfgang R. ; Buxhofer-Ausch, Veronika...
Wiener klinische Wochenschrift. 132 (2020) 15-16 - p. 415-422 , 2020

Link: https://doi.org/10.1007/..

2

The AST/ALT (De Ritis) ratio predicts clinical outcome in p..:

Riedl, Jakob Michael ; Posch, Florian ; Prager, Gerald...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883591990087 , 2020

Link: https://doi.org/10.1177/..

3

Rituximab maintenance overcomes the negative prognostic fac..:

Egle, Alexander ; Melchardt, Thomas ; Obrtlíková, Petra...
Cancer Medicine. 8 (2019) 4 - p. 1401-1405 , 2019

Link: https://doi.org/10.1002/..

4

A phase III randomized, multicentre, double blind, active c..:

Gisslinger, Heinz ; Buxhofer‐Ausch, Veronika ; Hodisch, Juri...
British Journal of Haematology. 185 (2019) 4 - p. 691-700 , 2019

Link: https://doi.org/10.1111/..

5

Ruxolitinib therapy for myelofibrosis in Austria: Consensus..:

Krauth, Maria-Theresa ; Burgstaller, Sonja ; Buxhofer-Ausch, Veronika...
Wiener klinische Wochenschrift. 130 (2018) 17-18 - p. 495-504 , 2018

Link: https://doi.org/10.1007/..

6

Establishment and validation of a novel risk model for esti..:

Huemer, Florian ; Weiss, Lukas ; Faber, Viktoria...
Wiener klinische Wochenschrift. 130 (2018) 3-4 - p. 115-125 , 2018

Link: https://doi.org/10.1007/..

7

Recurrent activating STAT5B N642H mutation in myeloid neopl..:

Cross, Nicholas C. P. ; Hoade, Yvette ; Tapper, William J....
Leukemia. 33 (2018) 2 - p. 415-425 , 2018

Link: https://doi.org/10.1038/..

8

Austrian recommendations for the management of polycythemia..:

Burgstaller, Sonja ; Buxhofer-Ausch, Veronika ; Sliwa, Thamer...
Wiener klinische Wochenschrift. 130 (2018) 17-18 - p. 535-542 , 2018

Link: https://doi.org/10.1007/..

9

Overexpression of the proneural transcription factor ASCL1 ..:

Malli, Theodora ; Rammer, Melanie ; Haslinger, Sabrina...
Molecular Cytogenetics. 11 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

10

Prognostic impact of a suboptimal number of analyzed metaph..:

de Swart, Louise ; Smith, Alex ; Haase, Detlef...
Leukemia Research. 67 (2018) - p. 21-26 , 2018

Link: https://doi.org/10.1016/..

11

Correction to: Ruxolitinib therapy formyelofibrosis in Aust..:

Krauth, Maria-Theresa ; Burgstaller, Sonja ; Buxhofer-Ausch, Veronika...
Wiener klinische Wochenschrift. 131 (2018) 1-2 - p. 47-47 , 2018

Link: https://doi.org/10.1007/..

12

Ixazomib in combination with carboplatin in pretreated wome..:

Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter ; Petzer, Andreas...
BMC Cancer. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

13

Clinical Outcomes of 217 Patients with Acute Erythroleukemi..:

Almeida, Antonio ; Prebet, Thomas ; Itzykson, Raphael...
International Journal of Molecular Sciences. 18 (2017) 4 - p. 837 , 2017

Link: https://doi.org/10.3390/..

14

Azacitidine for Front-Line Therapy of Patients with AML: Re..:

Pleyer, Lisa ; Döhner, Hartmut ; Dombret, Hervé...
International Journal of Molecular Sciences. 18 (2017) 2 - p. 415 , 2017

Link: https://doi.org/10.3390/..

15

A prospective, multicenter pilot study to investigate the f..:

on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG) ; Piringer, Gudrun ; Fridrik, Michael...
Supportive Care in Cancer. 26 (2017) 4 - p. 1345-1352 , 2017

Link: https://doi.org/10.1007/..